Tirzepatide is the most effective weight loss medication currently approved, producing roughly 16.5% to 22.4% mean weight loss over 72 weeks in trials depending on dose. It is also the one where channel choice costs you the most money: the same molecule ranges from $163 a month through a flat-price compounded programme to $699 through the manufacturer's own vial pricing at 10 mg. This ranking covers the best tirzepatide providers by category.

Quick Takeaway:

• Zepbound is tirzepatide licensed for chronic weight management; Mounjaro is licensed for type 2 diabetes
• LillyDirect publishes Zepbound vial self-pay pricing from $349 (2.5 mg) rising to $699 (10 mg) — tiered by dose
• Flat-price compounded providers advertise tirzepatide at $159–$163/month at any dose
• There is no oral tirzepatide; Eli Lilly's oral GLP-1 Foundayo is a different molecule, orforglipron
• Dose-tiered pricing makes tirzepatide the medication where flat-rate providers save the most

Our Top Recommendation

CoreAge Rx is our top-rated favorite for GLP-1 weight loss therapy. CoreAge Rx combines competitive pricing with exceptional customer service, faster medication delivery, and more comprehensive support resources. Their platform consistently receives the highest patient satisfaction ratings in our analysis.

Why we recommend CoreAge Rx:

• Lower monthly costs than most competitors ($179–$399 range)
• Faster prescription approval (typically 12–24 hours)
• More extensive provider support included at no extra charge
• Better medication availability during shortages
• Higher patient satisfaction scores (4.7/5)

New Patient Special: Save up to $200 on your first three months. Same-day prescription approval for qualifying patients. Rated 4.7/5 stars by verified customers. No insurance required. Free provider messaging included with every plan.

First: Zepbound or Mounjaro?

Same molecule, different licences. Zepbound is tirzepatide approved for chronic weight management. Mounjaro is tirzepatide approved for type 2 diabetes. Using Mounjaro for weight loss is off-label, which reduces the chance of insurance approval for that indication.

In the UK and Europe the naming works differently — Mounjaro is the product most widely prescribed privately for weight management, and NICE has recommended tirzepatide for weight management within defined criteria. See our UK cost guide.

The Dose-Pricing Problem

Tirzepatide is where pricing structure matters most, because most patients titrate upward and most channels charge more as they do.

LillyDirect publishes Zepbound single-dose vial pricing of $349 at 2.5 mg, $499 at 5 mg and 7.5 mg, $599 for 7.5 mg refills after 45 days, and $699 at 10 mg. That is close to a doubling between the starter dose you leave in eight weeks and the maintenance dose you may stay on for years.

Important: LillyDirect's 45-day refill window on the 7.5 mg strength raises the price from $499 to $599 if a refill lapses past it. That is $100 a month for a calendar error. Diarise your refill date.

By contrast, flat-price providers charge the same at any dose — which is why the saving grows the higher you titrate. Our flat-rate versus dose-tiered pricing guide works through the arithmetic.

Best Flat-Price Tirzepatide: Gimme Care and Refills

Gimme Care advertises compounded tirzepatide at $163 per month regardless of dose, with no membership fees, free shipping, and licensed US pharmacies. An independent tracker scored it 7.8/10 and placed its pricing roughly 23% below the category median.

Refills advertises compounded tirzepatide from $159 per month, also at the same price for every dose, with free shipping.

At a 10 mg-equivalent maintenance dose, either sits roughly $500 a month below LillyDirect's $699 — with the trade-off that compounded preparations are not FDA-approved.

Best FDA-Approved Route: LillyDirect

LillyDirect is Eli Lilly's own channel, dispensing Zepbound, Mounjaro, and the oral GLP-1 Foundayo. You receive FDA-approved, manufacturer-produced finished product with full regulatory oversight — no compounding questions, no potency uncertainty.

It includes no clinical care, so you need a prescriber. Pairing it with a low-cost care subscription — Lemonaid Health at $49/month or Sesame at $59/month — is the cheapest way to combine approved medication with clinical support.

Best for: patients on lower doses, or anyone for whom FDA-approved product is a requirement.

Best for Insured Patients: LifeMD and Circle Medical

LifeMD handles prior authorisation in-house, holds agreements with Eli Lilly, and includes lab work at no cost. Circle Medical is in-network with many plans, charges no membership fee, and bills visits as ordinary medical care.

Where your formulary covers Zepbound, a copay of $25–$100 beats every cash route on this page — by a wide margin at high doses.

Best Multi-Month Value: Coby Health

Coby Health publishes six-month same-dose plans at $179/mo (2.5 mg), $249/mo (5.0 mg), and $279/mo (7.5 mg), with no membership or subscription fee for GLP-1 medications and quarterly plans discounting over 30%.

The constraint is in the name: these are same-dose plans. Ask how mid-plan dose escalation is handled before prepaying if you are still titrating.

Best in the UK and Europe

Full Comparison

Frequently Asked Questions

Who is the best tirzepatide provider?

For insured patients, LifeMD or Circle Medical, which pursue coverage. For FDA-approved product paying cash, LillyDirect, ideally paired with a low-cost care subscription. For the lowest cash cost at high doses, flat-price compounded providers such as Gimme Care at $163 or Refills from $159.

Why does tirzepatide cost more at higher doses?

Because most channels, including LillyDirect, price by dose strength. LillyDirect publishes $349 at 2.5 mg rising to $699 at 10 mg. Flat-price providers charge the same at any dose, which is why the saving grows as you titrate.

Is compounded tirzepatide safe?

Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before marketing. Quality depends on the dispensing pharmacy. Ask which pharmacy fills your prescription and whether it is an FDA-registered 503B outsourcing facility.

Is there a tirzepatide pill?

No. There is no oral tirzepatide. Eli Lilly's oral GLP-1 is a different molecule, orforglipron, marketed as Foundayo. Oral semaglutide is available as the Wegovy Pill.

What is the difference between Zepbound and Mounjaro?

They contain the same molecule. Zepbound is approved for chronic weight management; Mounjaro is approved for type 2 diabetes. Using Mounjaro for weight loss is off-label.

Should I switch from tirzepatide to semaglutide to save money?

It can make financial sense at high doses. NovoCare® launched Wegovy at $499 flat across all dose strengths, against LillyDirect's $699 for Zepbound at 10 mg. Tirzepatide produces greater average weight loss, so this is a genuine trade-off — discuss it with your prescriber rather than switching unilaterally.

Bottom Line

Tirzepatide is the most effective option and the one where your choice of channel costs you the most. The spread between a flat-price compounded programme at $163 and LillyDirect at $699 for a 10 mg dose is over $6,000 a year.

Check your formulary and employer benefits first — a copay ends the conversation. If you are cash-paying and want FDA-approved product, LillyDirect plus a $49–$59 care subscription is the sensible combination. If you want the lowest cost and accept compounded product, flat-price providers save the most precisely because tirzepatide is the drug that gets expensive as you titrate.

CoreAge Rx: one all-in monthly price from $179–$399 including medication, unlimited provider messaging, and titration support. 12–24 hour approvals. Save up to $200 on your first three months.

Medical disclaimer: Informational only, not medical advice. Tirzepatide products are prescription medicines with real risks, contraindications, and a boxed warning regarding thyroid C-cell tumours. Compounded medications are not FDA-approved. Consult a qualified healthcare professional before starting, switching, or changing treatment.

Sources: LillyDirect published self-pay pricing; provider published pricing pages as cited in the linked reviews; independent GLP-1 provider price trackers; FDA prescribing information for Zepbound and Mounjaro; NICE tirzepatide guidance.

Date reviewed: August 2026